E-LIB Suche - Ergebnisse für: Kamath, Nikhil

1

Comparative Pharmacokinetics and Safety Assessment of 1st‐ ..:

Mai, Tu H. ; Yadav, Rajbharan ; Arjomandi, Audrey...
Clinical Pharmacology in Drug Development. 13 (2024) 6 - p. 655-664 , 2024

Link: https://doi.org/10.1002/..

2

Idiopathic pulmonary fibrosis therapy development: a clinic..:

Mai, Tu H. ; Han, Lyrialle W. ; Hsu, Joy C...
Therapeutic Advances in Respiratory Disease. 17 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

3

Long-term evaluation of the safety and efficacy of recombin..:

Raghu, Ganesh ; Hamblin, Mark J. ; Brown, A. Whitney...
Respiratory Research. 23 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

4

Efficacy, safety, and tolerability of lebrikizumab in adole..:

Szefler, Stanley J. ; Roberts, Graham ; Rubin, Adalberto S....
Clinical and Translational Allergy. 12 (2022) 7 - p. , 2022

Link: https://doi.org/10.1002/..

5

Evaluation of inpatient postpartum recovery using the Obste..:

Sultan, Pervez ; Kamath, Nikhil ; Carvalho, Brendan...
American Journal of Obstetrics & Gynecology MFM. 2 (2020) 4 - p. 100202 , 2020

Link: https://doi.org/10.1016/..

6

Rapid Lung Function Improvement with Lebrikizumab in Patien..:

Corren, Jonathan ; Hanania, Nicola A. ; Korenblat, Phillip E....
Journal of Allergy and Clinical Immunology. 137 (2016) 2 - p. AB13 , 2016

Link: https://doi.org/10.1016/..

7

Type 2 Biomarkers Define a Prevalent Phenotype in Moderate-..:

Korenblat, Phillip E. ; Hanania, Nicola A. ; Corren, Jonathan...
Journal of Allergy and Clinical Immunology. 137 (2016) 2 - p. AB108 , 2016

Link: https://doi.org/10.1016/..

8

Omalizumab in patients with symptomatic chronic idiopathic/..:

Kaplan, Allen ; Ledford, Dennis ; Ashby, Mark...
Journal of Allergy and Clinical Immunology. 132 (2013) 1 - p. 101-109 , 2013

Link: https://doi.org/10.1016/..

9

TAKEN: A Traffic Knowledge-Based Navigation System for Conn..:

Kamath B, Nikhil ; Fernandes, Roshan ; Rodrigues, Anisha P....
Sensors. 23 (2023) 2 - p. 653 , 2023

Link: https://doi.org/10.3390/..

10

Dynamic resource management using gesture-based user interf..:

, In: 20th Annual International Conference on Advanced Computing and Communications (ADCOM),

Sripradha K ; Nikhil Kamath K ; Nilesh Nayak H. - p. 1-6 , 2014

Link: https://doi.org/10.1109/..

11

Idiopathic pulmonary fibrosis therapy development: a clinic..:

Mai, Tu H ; Han, Lyrialle W ; Hsu, Joy C..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333628/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Efficacy, safety, and tolerability of lebrikizumab in adole..:

Szefler, Stanley J ; Roberts, Graham ; Rubin, Adalberto S...
https://eprints.soton.ac.uk/476988/1/Efficacy_safety_and_tolerability_of_lebrikizumab.pdf. , 2022

Link: https://eprints.soton.ac..

13

Efficacy, safety, and tolerability of lebrikizumab in adole..:

Szefler, Stanley J ; Roberts, Graham ; Rubin, Adalberto S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281483/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Nurturing Global Leadership, Advocacy, Research, and Colleg..:

Karam, Sabine ; Abdul Hafidz, Muhammad Iqbal ; Calice-Silva, Viviane...
Kidney International Reports. 8 (2023) 9 - p. 1703-1707 , 2023

Link: https://doi.org/10.1016/..

15

Barriers to accessing essential medicines for kidney diseas..:

Francis, Anna ; Abdul Hafidz, Muhammad Iqbal ; Ekrikpo, Udeme E....
Kidney International. 102 (2022) 5 - p. 969-973 , 2022

Link: https://doi.org/10.1016/..